By Professor Glenda Halliday

Journal articles

Hu Q; Li T; Wang L; Xie Y; Liu S; Bai X; Zhang T; Bo S; Xin D; Xue H; Li G; Wang Z, 2016, 'Neuroprotective Effects of a Smoothened Receptor Agonist against Early Brain Injury after Experimental Subarachnoid Hemorrhage in Rats.', Front Cell Neurosci, 10, pp. 306, http://dx.doi.org/10.3389/fncel.2016.00306

van Eersel J; Stevens CH; Przybyla M; Gladbach A; Stefanoska K; Chan CKX; Ong WY; Hodges JR; Sutherland GT; Kril JJ; Abramowski D; Staufenbiel M; Halliday GM; Ittner LM, 2015, 'Early-onset axonal pathology in a novel P301S-Tau transgenic mouse model of frontotemporal lobar degeneration', Neuropathology and Applied Neurobiology, 41, pp. 906 - 925, http://dx.doi.org/10.1111/nan.12233

Devenney E; Bartley L; Hoon C; O'Callaghan C; Kumfor F; Hornberger M; Kwok JB; Halliday GM; Kiernan MC; Piguet O; Hodges JR, 2015, 'Progression in behavioral variant frontotemporal dementia: A longitudinal study', JAMA Neurology, 72, pp. 1501 - 1509, http://dx.doi.org/10.1001/jamaneurol.2015.2061

Leshchyns'Ka I; Liew HT; Shepherd C; Halliday GM; Stevens CH; Ke YD; Ittner LM; Sytnyk V, 2015, 'Aβ-dependent reduction of NCAM2-mediated synaptic adhesion contributes to synapse loss in Alzheimer's disease', Nature Communications, 6, http://dx.doi.org/10.1038/ncomms9836

Helmfors L; Boman A; Civitelli L; Nath S; Sandin L; Janefjord C; McCann H; Zetterberg H; Blennow K; Halliday G; Brorsson AC; Kågedal K, 2015, 'Protective properties of lysozyme on β-amyloid pathology: Implications for Alzheimer disease', Neurobiology of Disease, 83, pp. 122 - 133, http://dx.doi.org/10.1016/j.nbd.2015.08.024

Ke YD; van Hummel A; Stevens CH; Gladbach A; Ippati S; Bi M; Lee WS; Krüger S; van der Hoven J; Volkerling A; Bongers A; Halliday G; Haass NK; Kiernan M; Delerue F; Ittner LM, 2015, 'Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS', Acta Neuropathologica, 130, pp. 661 - 678, http://dx.doi.org/10.1007/s00401-015-1486-0

Ahmed RM; Latheef S; Bartley L; Irish M; Halliday GM; Kiernan MC; Hodges JR; Piguet O, 2015, 'Eating behavior in frontotemporal dementia', Neurology, 85, pp. 1310 - 1317, http://dx.doi.org/10.1212/WNL.0000000000002018

Rusznák Z; Kim WS; Hsiao JHT; Halliday GM; Paxinos G; Fu YH, 2015, 'Early in vivo effects of the human mutant amyloid-β protein precursor (hAβPPSwInd) on the mouse olfactory bulb', Journal of Alzheimer S Disease, 49, pp. 443 - 457, http://dx.doi.org/10.3233/JAD-150368

Dobson-Stone C; Shaw AD; Hallupp M; Bartley L; McCann H; Brooks WS; Loy CT; Schofield PR; Mather KA; Kochan NA; Sachdev PS; Halliday GM; Piguet O; Hodges JR; Kwok JBJ; Schofield P, 2015, 'Is CHCHD10 Pro34Ser pathogenic for frontotemporal dementia and amyotrophic lateral sclerosis?', Brain, 138, pp. e385, http://dx.doi.org/10.1093/brain/awv115

Lourenco GF; Janitz M; Huang Y; Halliday GM, 2015, 'Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD)', Neurobiology of Disease, 82, pp. 445 - 454, http://dx.doi.org/10.1016/j.nbd.2015.07.011

Murphy KE; Gysbers AM; Abbott SK; Spiro AS; Furuta A; Cooper A; Garner B; Kabuta T; Halliday GM, 2015, 'Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease', Movement Disorders, 30, pp. 1639 - 1647, http://dx.doi.org/10.1002/mds.26141

Postuma RB; Berg D; Stern M; Poewe W; Olanow CW; Oertel W; Obeso J; Marek K; Litvan I; Lang AE; Halliday G; Goetz CG; Gasser T; Dubois B; Chan P; Bloem BR; Adler CH; Deuschl G, 2015, 'MDS clinical diagnostic criteria for Parkinson's disease', Movement Disorders, 30, pp. 1591 - 1601, http://dx.doi.org/10.1002/mds.26424

Berg D; Postuma RB; Adler CH; Bloem BR; Chan P; Dubois B; Gasser T; Goetz CG; Halliday G; Joseph L; Lang AE; Liepelt-Scarfone I; Litvan I; Marek K; Obeso J; Oertel W; Olanow CW; Poewe W; Stern M; Deuschl G, 2015, 'MDS research criteria for prodromal Parkinson's disease', Movement Disorders, 30, pp. 1600 - 1611, http://dx.doi.org/10.1002/mds.26431

Gabery S; Halliday G; Kirik D; Englund E; Petersén Å, 2015, 'Selective loss of oxytocin and vasopressin in the hypothalamus in early Huntington disease: A case study', Neuropathology and Applied Neurobiology, 41, pp. 843 - 848, http://dx.doi.org/10.1111/nan.12236

Tan RH; Kril JJ; Fatima M; McGeachie A; McCann H; Shepherd C; Forrest SL; Affleck A; Kwok JBJ; Hodges JR; Kiernan MC; Halliday GM, 2015, 'TDP-43 proteinopathies: Pathological identification of brain regions differentiating clinical phenotypes', Brain, 138, pp. 3110 - 3122, http://dx.doi.org/10.1093/brain/awv220

Cordato NJ; Halliday GM, 2015, 'The differentiation of progressive supranuclear palsy', Neurodegenerative Disease Management, 5, pp. 385 - 388, http://dx.doi.org/10.2217/nmt.15.37

Mccann H; Fung VSC; Klein C; Halliday GM, 2015, 'Unusual α-synuclein and cerebellar pathologies in a case of hereditary myoclonus-dystonia without SGCE mutation', Neuropathology and Applied Neurobiology, 41, pp. 837 - 842, http://dx.doi.org/10.1111/nan.12216

Prusiner SB; Woerman AL; Mordes DA; Watts JC; Rampersaud R; Berry DB; Patel S; Oehler A; Lowe JK; Kravitz SN; Geschwind DH; Glidden DV; Halliday GM; Middleton LT; Gentleman SM; Grinberg LT; Giles K, 2015, 'Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism', Proceedings of the National Academy of Sciences of the United States of America, 112, pp. E5308 - E5317, http://dx.doi.org/10.1073/pnas.1514475112

Coupland KG; Kim WS; Halliday GM; Hallupp M; Dobson-Stone C; Kwok JBJ, 2015, 'Effect of PSEN1 mutations on MAPT methylation in early-onset Alzheimer’s disease', Current Alzheimer Research, 12, pp. 745 - 751, http://dx.doi.org/10.2174/1567205012666150710110756

Dzamko N; Geczy CL; Halliday GM, 2015, 'Inflammation is genetically implicated in Parkinson's disease', Neuroscience, 302, pp. 89 - 102, http://dx.doi.org/10.1016/j.neuroscience.2014.10.028

Cairns NJ; Perrin RJ; Franklin EE; Carter D; Vincent B; Xie M; Bateman RJ; Benzinger T; Friedrichsen K; Brooks WS; Halliday GM; Mclean C; Ghetti B; Morris JC, 2015, 'Neuropathologic assessment of participants in two multi-center longitudinal observational studies: The Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN)', Neuropathology, 35, pp. 390 - 400, http://dx.doi.org/10.1111/neup.12205

Halliday GM, 2015, 'Re-evaluating the glio-centric view of multiple system atrophy by highlighting the neuronal involvement', Brain, 138, pp. 2116 - 2119, http://dx.doi.org/10.1093/brain/awv151

Fatima M; Tan R; Halliday GM; Kril JJ, 2015, 'Spread of pathology in amyotrophic lateral sclerosis: assessment of phosphorylated TDP-43 along axonal pathways', Acta Neuropathologica Communications, 3, pp. 47, http://dx.doi.org/10.1186/s40478-015-0226-y

Mills JD; Chen J; Kim WS; Waters PD; Prabowo AS; Aronica E; Halliday GM; Janitz M, 2015, 'Long intervening non-coding RNA 00320 is human brain-specific and highly expressed in the cortical white matter', Neurogenetics, 16, pp. 201 - 213, http://dx.doi.org/10.1007/s10048-015-0445-1

Vaikath NN; Majbour NK; Paleologou KE; Ardah MT; van Dam E; van de Berg WDJ; Forrest SL; Parkkinen L; Gai WP; Hattori N; Takanashi M; Lee SJ; Mann DMA; Imai Y; Halliday GM; Li JY; El-Agnaf OMA, 2015, 'Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology', Neurobiology of Disease, 79, pp. 81 - 99, http://dx.doi.org/10.1016/j.nbd.2015.04.009

Ittner LM; Halliday GM; Kril JJ; Götz J; Hodges JR; Kiernan MC, 2015, 'FTD and ALS-translating mouse studies into clinical trials', Nature Reviews Neurology, 11, pp. 360 - 366, http://dx.doi.org/10.1038/nrneurol.2015.65

Shine JM; Mills JMZ; Qiu J; O'Callaghan C; Terpening Z; Halliday GM; Naismith SL; Lewis SJG, 2015, 'Validation of the Psychosis and Hallucinations Questionnaire in Non-demented Patients with Parkinson's Disease', Movement Disorders Clinical Practice, 2, pp. 175 - 181, http://dx.doi.org/10.1002/mdc3.12139

Duyckaerts C; Braak H; Brion JP; Buée L; Del Tredici K; Goedert M; Halliday G; Neumann M; Spillantini MG; Tolnay M; Uchihara T, 2015, 'PART is part of Alzheimer disease', Acta Neuropathologica, 129, pp. 749 - 756, http://dx.doi.org/10.1007/s00401-015-1390-7

Cheshire P; Ayton S; Bertram KL; Ling H; Li A; Mclean C; Halliday GM; O'Sullivan SS; Revesz T; Finkelstein DI; Storey E; Williams DR, 2015, 'Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias', Movement Disorders, 30, pp. 796 - 804, http://dx.doi.org/10.1002/mds.26144

Shine JM; Muller AJ; O'Callaghan C; Hornberger M; Halliday GM; Lewis SJG, 2015, 'Abnormal connectivity between the default mode and the visual system underlies the manifestation of visual hallucinations in Parkinson's disease: A task-based fMRI study', Parkinson S Disease, 1, http://dx.doi.org/10.1038/npjparkd.2015.3

Ahmed R; Henning E; Bartley L; Halliday G; Piguet O; Farooqi S; Hodges J; Kiernan M, 2015, 'Eating Behaviour and Metabolic Changes across the Spectrum of Motor Neuron Disease and Frontotemporal Dementia. (I12-5E)', Neurology, 84, http://dx.doi.org/10.1212/wnl.84.14_supplement.i12-5e

Ahmed R; Henning E; Bartley L; Halliday G; Piguet O; Farooqi S; Hodges J; Kiernan M, 2015, 'Eating Behaviour and Metabolic Changes across the Spectrum of Motor Neuron Disease and Frontotemporal Dementia. (P1.225)', Neurology, 84, http://dx.doi.org/10.1212/wnl.84.14_supplement.p1.225

Halliday GM; Murphy KE, 2015, 'Reply: Lysosomal dysfunction in Parkinson's disease', Brain, 138, pp. e340, http://dx.doi.org/10.1093/brain/awu268

Mills JD; Kim WS; Halliday GM; Janitz M, 2015, 'Transcriptome analysis of grey and white matter cortical tissue in multiple system atrophy', Neurogenetics, 16, pp. 107 - 122, http://dx.doi.org/10.1007/s10048-014-0430-0

Yang Y; Shepherd C; Halliday G, 2015, 'Aneuploidy in Lewy body diseases', Neurobiology of Aging, 36, pp. 1253 - 1260, http://dx.doi.org/10.1016/j.neurobiolaging.2014.12.016

Halliday G, 2015, 'Progressive supranuclear palsy finally has a clinically measureable τ abnormality', Journal of Neurology Neurosurgery and Psychiatry, 86, pp. 241, http://dx.doi.org/10.1136/jnnp-2014-308567

Mills JD; Kavanagh T; Kim WS; Chen BJ; Waters PD; Halliday GM; Janitz M, 2015, 'High expression of long intervening non-coding RNA OLMALINC in the human cortical white matter is associated with regulation of oligodendrocyte maturation', Molecular Brain, 8, pp. 2, http://dx.doi.org/10.1186/s13041-014-0091-9

Fu Y; Hsiao JHT; Paxinos G; Halliday GM; Kim WS, 2015, 'ABCA5 Regulates amyloid-β peptide production and is associated with Alzheimer's disease neuropathology', Journal of Alzheimer S Disease, 43, pp. 857 - 869, http://dx.doi.org/10.3233/JAD-141320

Abbott SK; Jenner AM; Spiro AS; Batterham M; Halliday GM; Garner B, 2015, 'Fatty acid composition of the anterior cingulate cortex indicates a high susceptibility to lipid peroxidation in Parkinson's disease', Journal of Parkinson S Disease, 5, pp. 175 - 185, http://dx.doi.org/10.3233/JPD-140479

Halliday GM; Forrest SL; Kril J, 2015, 'Frontotemporal lobar degeneration with tau inclusions (FTLD-tau): Recent developments in pathology and pathogenesis', Australian Biochemist, 46, pp. 8 - 11

McCann H; McGeachie AB; Silberstein P; Lewis SJG; Halliday GM, 2015, 'Restricted disease propagation in multiple system atrophy with prolonged survival', Neuropathology and Applied Neurobiology, 41, pp. 681 - 685, http://dx.doi.org/10.1111/nan.12195

Huang Y; Wang G; Rowe D; Wang Y; Kwok JBJ; Xiao Q; Mastaglia F; Liu J; Chen SD; Halliday G, 2015, 'SNCA gene, but not MAPT, influences onset age of Parkinson's disease in Chinese and Australians', Biomed Research International, 2015, pp. 135674, http://dx.doi.org/10.1155/2015/135674

Tan RH; Devenney E; Kiernan MC; Halliday GM; Hodges JR; Hornberger M, 2015, 'Terra incognita-cerebellar contributions to neuropsychiatric and cognitive dysfunction in behavioral variant frontotemporal dementia', Frontiers in Aging Neuroscience, 7, http://dx.doi.org/10.3389/fnagi.2015.00121

Szeto JYY; O'Callaghan C; Shine JM; Walton CC; Mowszowski L; Naismith SL; Halliday GM; Lewis SJG, 2015, 'The relationships between mild cognitive impairment and phenotype in Parkinson's disease', Parkinson S Disease, 1, http://dx.doi.org/10.1038/npjparkd.2015.15

Chen J; Mills JD; Halliday GM; Janitz M, 2015, 'The role of transcriptional control in multiple system atrophy', Neurobiology of Aging, 36, pp. 394 - 400, http://dx.doi.org/10.1016/j.neurobiolaging.2014.08.015

Sandin L; Nath S; Armstrong A; Janefjord C; McCann H; Halliday GM; Blennow K; Zetterberg H; Brorsson A-C; Kagedal K, 2015, 'P1‐316: The role of lysozyme in Alzheimer's disease', Alzheimer's & Dementia, 11, http://dx.doi.org/10.1016/j.jalz.2015.06.531

Ahmed RM; Paterson RW; Warren JD; Zetterberg H; O'Brien JT; Fox NC; Halliday GM; Schott JM, 2014, 'Biomarkers in dementia: Clinical utility and new directions', Journal of Neurology Neurosurgery and Psychiatry, 85, pp. 1426 - 1434, http://dx.doi.org/10.1136/jnnp-2014-307662

Stoessl AJ; Halliday GM, 2014, 'DAT-SPECT diagnoses dopamine depletion, but not PD', Movement Disorders, 29, pp. 1705 - 1706, http://dx.doi.org/10.1002/mds.26000

Bras J; Guerreiro R; Darwent L; Parkkinen L; Ansorge O; Escott-Price V; Hernandez DG; Nalls MA; Clark LN; Honig LS; Marder K; Van Der Flier WM; Lemstra A; Scheltens P; Rogaeva E; St George-Hyslop P; Londos E; Zetterberg H; Ortega-Cubero S; Pastor P; Ferman TJ; Graff-Radford NR; Ross OA; Barber I; Braae A; Brown K; Morgan K; Maetzler W; Berg D; Troakes C; Al-Sarraj S; Lashley T; Compta Y; Revesz T; Lees A; Cairns N; Halliday GM; Mann D; Pickering-Brown S; Dickson DW; Singleton A; Hardy J, 2014, 'Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies', Human Molecular Genetics, 23, pp. 6139 - 6146, http://dx.doi.org/10.1093/hmg/ddu334

Ahmed RM; MacMillan M; Bartley L; Halliday GM; Kiernan MC; Hodges JR; Piguet O, 2014, 'Systemic metabolism in frontotemporal dementia', Neurology, 83, pp. 1812 - 1818, http://dx.doi.org/10.1212/WNL.0000000000000993

Back to profile page